Angeles Therapeutics
Pre-clinicalAngeles Therapeutics is a next generation cell therapy company with novel chimeric antigen receptor T cell (CAR-T) and NK cell (CAR-NK) platforms.
Founded
2020
Focus
Cell & Gene Therapy
About
Angeles Therapeutics is a next generation cell therapy company with novel chimeric antigen receptor T cell (CAR-T) and NK cell (CAR-NK) platforms.
Funding History
437Total raised: $224.4M
Grant$583KNHLBISep 6, 2025
Grant$46KNIGMSDec 9, 2024
Grant$393KNIASep 25, 2024
Grant$2MNIDDKSep 24, 2024
Company Info
TypePrivate
Founded2020
LocationLos Angeles, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile